PROS1 mutations associated with protein S deficiency in Polish patients with residual vein obstruction on rivaroxaban therapy

Thrombosis Research

Volumn 134, Issue 1, 2014, Pages 199-201

  Wypasek, Ewa ^a,b   Potaczek, Daniel P ^a,c   Alhenc Gelas, Martine ^d   Undas, Anetta ^a,b  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ENOXAPARIN; PROTEIN S; RIVAROXABAN; WARFARIN; MORPHOLINE DERIVATIVE; PLASMA PROTEIN; PROS1 PROTEIN, HUMAN; THIOPHENE DERIVATIVE;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTIFICIAL EMBOLISM; BUERGER DISEASE; CLINICAL ARTICLE; CODON; DEEP VEIN THROMBOSIS; DISEASE COURSE; ECHOGRAPHY; EXON; FAMILY HISTORY; FEMALE; FEMORAL VEIN; GENE DUPLICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; INTERNATIONAL NORMALIZED RATIO; INTRON; LEG AMPUTATION; LEG VARICOSIS; LETTER; LONG TERM CARE; MALE; MESENTERIC ISCHEMIA; MIDDLE AGED; OBESITY; PEDIGREE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL VEIN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN S DEFICIENCY; SWELLING; THROMBOPHILIA; VEIN OCCLUSION; YOUNG ADULT; CASE REPORT; GENETICS; METABOLISM; MUTATION; POLAND; VENOUS THROMBOSIS;

ADOLESCENT; ADULT; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MORPHOLINES; MUTATION; POLAND; PROTEIN S DEFICIENCY; THIOPHENES; VENOUS THROMBOSIS;

EID: 84902540444     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.01.023     Document Type: Letter

References (17)

1. B. Dahlback Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein J Biol Chem 261 1986 12022 12027
2. B. Dahlbäck Advances in understanding pathogenic mechanisms of thrombophilic disorders Blood 112 2008 19 27
3. L.F. Maurissen, M.C. Thomassen, G.A. Nicolaes, B. Dahlbäck, G. Tans, and J. Rosing et al. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation Blood 6 2008 3034 3041
4. R.H. van de Poel, J.C. Meijers, and B.N. Bouma C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa Thromb Haemost 85 2001 761 765
5. T. Hackeng, K.M. Sere, G. Tans, and J. Rosing Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor Proc Natl Acad Sci 103 2006 3106 3111
6. P. García de Frutos, P. Fuentes-Prior, B. Hurtado, and N. Sala Molecular basis of protein S deficiency Thromb Haemost 98 2007 543 556
7. Z. Bereczky, K.B. Kovács, and L. Muszbek Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game Clin Chem Lab Med 48 2010 S53 S66
8. M. Alhenc Gelas, F. Juin, E. de Raucourt, S. Gandrille, D. Borgel, and M. Aiach Influence of PROS1 gene mutations affecting protein S amino-acid 275 on plasma free protein S measurement Thromb Haemost 97 2007 678 680
9. E. Wypasek, M. Alhenc-Gelas, and A. Undas First report of a large PROS1 deletion from exon 1 through 12 detected in Polish patients with deep-vein thrombosis Thromb Res 132 2013 143 144
10. E. Wypasek, P.D. Potaczek, M. Alhenc-Gelas, and A. Undas Heerlen polymorphism associated with type III protein S deficiency and factor V mutation in a Polish patient with deep vein thrombosis Blood Coagul Fibrinolysis 25 2014 84 85
11. M. Carrier, M.A. Rodger, P.S. Wells, M. Righini, and G. LE Gal Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis J Thromb Haemost 6 2011 1119 1125
12. K. Zawilska, M.M. Bała, P. Błȩdowski, D.W. Chmielewski, Z. Dobrowolski, and M. Fra̧czek et al. Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update Pol Arch Med Wewn 122 2012 3 74
13. M.M. Samama The mechanism of action of rivaroxaban - an oral, direct Factor Xa inhibitor-compared with other anticoagulants Thromb Res 6 2011 497 504
14. EINSTEIN-Investigators Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
15. EINSTEIN-PE Investigators Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
16. I. Martinelli, P. Bucciarelli, A. Artoni, E.F. Fossali, S.M. Passamonti, and A. Tripodi et al. Anticoagulant treatment with rivaroxaban in severe protein S deficiency Pediatrics 5 2013 e1435 e1439
17. S. Peraramelli, J. Rosing, and T.M. Hackeng TFPI-dependent activities of protein S Thromb Res 129 2012 S23 S26